Drug giant AstraZeneca (AZN) has bought Boston-based Modella AI to speed up its cancer research work.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The aim is to integrate Modella’s AI agents into AZN’s oncology research and development. AZN’s shares were lower in mid-trading.